We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Test Report for Blood Pressure Meter CH-609

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01044849
First Posted: January 8, 2010
Last Update Posted: January 8, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Citizen Systems Japan Co., Ltd.
  Purpose
Blood pressure meter model CH-609 was to be assessed against the standard mercury sphygmomanometer according to the protocol of the ANSI/AAMI SP-10.

Condition
Blood Pressure

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional

Further study details as provided by Citizen Systems Japan Co., Ltd.:

Primary Outcome Measures:
  • Measure the accuracy of blood pressure meter model CH-609 against the standard mercury sphygmomanometer according to the protocol of ANSI/AAMI SP-10. [ Time Frame: 30 minutes ]

Enrollment: 85
Study Start Date: November 2007
Study Completion Date: January 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   22 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Community Sample
Criteria

Inclusion Criteria:

  • 85 subjects with a wide range of blood pressure were selected.

Exclusion Criteria:

  • Subjects could be taking antihypertensive medication, but excluded in atrial fibrillation or with any sustained arrhythmia.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01044849


Locations
Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Sponsors and Collaborators
Citizen Systems Japan Co., Ltd.
  More Information

Responsible Party: Makoto Okamoto, Citizen Systems Japan Co., Ltd.
ClinicalTrials.gov Identifier: NCT01044849     History of Changes
Other Study ID Numbers: CH-609
First Submitted: January 7, 2010
First Posted: January 8, 2010
Last Update Posted: January 8, 2010
Last Verified: January 2010

Keywords provided by Citizen Systems Japan Co., Ltd.:
Blood Pressure